No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / metabolism
-
Adrenergic beta-Antagonists / therapeutic use
-
Age Factors
-
Antihypertensive Agents / metabolism
-
Antihypertensive Agents / therapeutic use
-
Cytochrome P-450 Enzyme System / metabolism*
-
Depression / drug therapy*
-
Diuretics / metabolism
-
Diuretics / therapeutic use
-
Drug Interactions*
-
Drug-Related Side Effects and Adverse Reactions*
-
Heart Failure / drug therapy*
-
Humans
-
Metoprolol / metabolism
-
Metoprolol / therapeutic use
-
Paroxetine / metabolism
-
Paroxetine / therapeutic use
-
Polypharmacy*
-
Risk Factors
-
Sulfonamides / metabolism
-
Sulfonamides / therapeutic use
-
Torsemide
Substances
-
Adrenergic beta-Antagonists
-
Antihypertensive Agents
-
Diuretics
-
Sulfonamides
-
Paroxetine
-
Cytochrome P-450 Enzyme System
-
Metoprolol
-
Torsemide